Multiple Effects of Ascorbic Acid against Chronic Diseases: Updated Evidence from Preclinical and Clinical Studies
Massimiliano Berretta(University of Messina), Monica Montopoli(University of Padua), Raffaele Di Francia(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Michela Piezzo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giuseppe Nunnari(University of Catania), Gaetano Facchini(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Nicola Maurea(Cancer Institute (WIA)), Saman Sharifi(University of Padua), Luca Rinaldi(University of Molise), Ceccarelli Manuela(University of Catania), Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 87
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
|International Journal of Molecular Sciences|2020|194
Epithelial-mesenchymal transition in prostate cancer: an overview
|Oncotarget|2017|177
Metabolic Plasticity in Chemotherapy Resistance
|Frontiers in Oncology|2020|175
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116